You are here

  • Home
  • Archive
  • Volume 17, Issue 3
  • Tiotropium is superior to salmeterol in reducing frequency of exacerbations: but the effect of adding tiotropium to the combination of inhaled corticosteroid and long-acting β(2)-agonist remains unclear

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Tiotropium is superior to salmeterol in reducing frequency of exacerbations: but the effect of adding tiotropium to the combination of inhaled corticosteroid and long-acting β(2)-agonist remains unclear

https://doi.org/10.1136/ebmed.2011.100206

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests RH has received research grants, consulting and speaking honoraria from AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Novartis, Nycomed.